Skip to Content

Kali Inc KALY

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

KALY is trading at a 29% discount.
Price
$0.00
Fair Value
$7.27
Uncertainty
Extreme
1-Star Price
$1.81
5-Star Price
$6.20
Economic Moat
Gvfh
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if KALY is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$2.64
Volume/Avg
38,000 / 96,434

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

Kali Inc is a United States based company involved in cannabis extraction business. It focuses on development of pharmaceuticals to treat various illnesses, diseases and chronic pain as a symptom of various diagnoses. The company also concentrates on the development of health and wellness therapies.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
171

Valuation

Metric
KALY
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
KALY

Financial Strength

Metric
KALY
Quick Ratio
5.17
Current Ratio
5.33
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
KALY
Return on Assets (Normalized)
28.86%
Return on Equity (Normalized)
35.09%
Return on Invested Capital (Normalized)
34.63%
Return on Assets
No chart available

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AXcms$84.8 Bil
MKKGY
Merck KGaA ADRHlysvh$66.6 Bil
HLN
Haleon PLC ADRVmhy$37.8 Bil
VTRS
Viatris IncPcfg$11.8 Bil
RDY
Dr Reddy's Laboratories Ltd ADRJft$11.5 Bil
CTLT
Catalent IncGkbjpv$6.7 Bil
PRGO
Perrigo Co PLCQqskw$4.0 Bil
CURLF
Curaleaf Holdings IncMscm$3.1 Bil
PBH
Prestige Consumer Healthcare IncPqgfn$3.0 Bil
GTBIF
Green Thumb Industries IncLtxxf$2.7 Bil